Answers are grounded in this paper and cite their sources.
Motivation Characterizing the intratumoral heterogeneity of Lung Adenocarcinoma (LUAD) from bulk transcriptomics is critical for precision medicine, yet conventional deconvolution methods are limited by high computational latency and sensitivity to transcriptomic noise, hindering their application to large-scale clinical trials. To overcome these barriers, we present a Deep Neural Network (DNN) emulator that shifts the deconvolution task from iterative optimization to rapid functional inference. Results Utilizing a harmonized LUAD single-cell atlas, we engineered a synthetic training environment of 1,000 heterogeneous bulk profiles to train a pathway-guided architecture. By internalizing the complex transformation mappings of marker-based deconvolution, our model reproduces TOAST estimates of four previously defined LUAD cancer cell states on held-out synthetic samples (ensemble mean Spearman ρ = 0.87, MAE = 0.067), agrees with the reference-based method BayesPrism about as well as TOAST itself does (mean ρ = 0.57 for both), and runs at 1.4 ms per sample for a single model and 12.5 ms for the ensemble, similar to TOAST and about 100 to 900 times faster than BayesPrism. We applied this emulator to large-scale clinical cohorts to estimate the proportion of the high-risk, dedifferentiated state, characterized by hypoxia and EMT. The predicted proportion of this state was associated with shorter overall survival in all six cohorts (pooled hazard ratio 1.70, 95% CI 1.49–1.95, for top versus bottom tertile), suggesting that our emulator provides a scalable and biologically grounded framework for patient stratification and the translation of single-cell insights into clinical practice. Availability and implementation The analysis code is freely available on GitHub (https://github.com/bsoni08/emulator_luad_stratification) and implemented in Python using TensorFlow alongside R scripts. Contact Inquiries can be directed to bsoni08@gmail.com, christopher.yau@wrh.ox.ac.uk, or ines.grazina_de_matos@roche.com.
No takes yet. Share an insight, caveat, or question.
Soni et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: